These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7805084)

  • 21. Adjunctive pharmacologic therapy in percutaneous coronary intervention: part II anticoagulant therapy.
    Kim SJ; Giugliano RP; Jang IK
    Coron Artery Dis; 2011 Mar; 22(1):113-21. PubMed ID: 21304293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of thrombotic and cardiovascular disorders in the new millenium.
    Fareed J; Hoppensteadt DA; Bick RL
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
    Weber MA; Lorenz RL; Schramm W; Theisen K
    Z Kardiol; 1986; 75 Suppl 5():107-11. PubMed ID: 2950673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic and thrombolytic therapy in patients undergoing coronary artery interventions: a review.
    Schwartz L; Seidelin PH
    Prog Cardiovasc Dis; 1995; 38(1):67-86. PubMed ID: 7631021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment].
    Melandri G; Semprini F; Cervi V; Candiotti N; Branzi A
    Cardiologia; 1994 Dec; 39(12 Suppl 1):347-52. PubMed ID: 7634295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty.
    Monsen CH; Adams PC; Badimon L; Chesebro JH; Fuster V
    Z Kardiol; 1987; 76 Suppl 6():23-8. PubMed ID: 2964144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials of primary and secondary prevention of thrombosis and restenosis.
    Vermylen J
    Thromb Haemost; 1995 Jul; 74(1):377-81. PubMed ID: 8578489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty.
    Boston DR; Malouf A; Barry WH
    Clin Cardiol; 1996 Jul; 19(7):536-42. PubMed ID: 8818433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombotic therapy in heart failure: what conclusions can be drawn?
    Cokkinos DV
    J Cardiovasc Risk; 1995 Apr; 2(2):118-21. PubMed ID: 7606648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The promises of new antithrombotic agents].
    Camez A; Levy D
    Rev Prat; 1992 Nov; 42(17):2151-5. PubMed ID: 1290037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological antithrombotic adjuncts to percutaneous coronary intervention.
    Lucking AJ; Newby DE
    Expert Opin Pharmacother; 2007 Apr; 8(6):759-76. PubMed ID: 17425472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [-Differential antithrombotic therapy in patients with low and high PTCA risk-].
    Silber S; Dörr R
    Herz; 1996 Feb; 21(1):44-59. PubMed ID: 8647579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in the development of anticoagulant and antithrombotic drugs.
    Fareed J; Hoppensteadt D; Walenga JM; Bick RL
    Med Clin North Am; 1994 May; 78(3):713-31. PubMed ID: 8170266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin, and G-4120.
    Stockmans F; Stassen JM; Vermylen J; Hoylaerts MF; Nyström A
    Ann Plast Surg; 1997 Jan; 38(1):63-8. PubMed ID: 9015542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin activity during percutaneous coronary angioplasty].
    Orzan F; Brusca A
    Cardiologia; 1991 Dec; 36(12 Suppl 1):221-3. PubMed ID: 1841773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in antiplatelet and antithrombotic therapy.
    Verstraete M
    Eur Heart J; 1995 Nov; 16 Suppl L():16-23. PubMed ID: 8869014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin and antithrombotic therapy in interventional cardiology.
    Herrman JP; Serruys PW
    Tex Heart Inst J; 1994; 21(2):138-47. PubMed ID: 8061538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.